IC17 Gout Flashcards
goals of treatment
- Provide rapid, safe & effective pain relief
- Reduce future attacks (reduce serum urate)
patho of gout
basically, incr in purine/ uric acid which leads to urate crystal formation in synovial fluid
pharmacotherapy approach in gout (first acute gouty arthritis / subsequent flares)
Colchicine preferred if present within 24-36h;
Other choices: NSAIDs, corticosteroids
clinical presentation
severe pain, usually monoarticular at 1st MTP of great toe
Treatment goal for non-tophaceous gout in ULT
< 360 umol/L (6mg/dL)
Dose for colchicine
Once-off: Loading dose 1mg, f/b 0.5mg 1h later
OR
0.5mg BD or TDS, until acute flare resolves
Max: 1.5mg/day
Dose for NSAIDs
Celecoxib 400mg loading, f/b 200mg BD
Max: 400mg/day
Dose for corticosteroids
Prednisolone 30-40mg/day OR 0.5mg/kg/day
When to initiate ULT
Any of following:
- Hx of urolithiasis
- Presence of tophus
- 2 or more acute gout per year
- Clinical/ imaging finding of gouty arthropathy
Transporters that reabsorb uric acid in kidney
URAT-1, GLUT-9
MOA of pegloticase (not avail in SG)
Incr uric acid metabolism; Converts uric acid to allantoin
MOA of lesinurad (not avail in SG)
Incr uric acid excretion; Selective URAT1 inhibitor
Dose for allopurinol
- initiation: ≤ 100mg/day [CKD stage ≥ 3: ≤ 50mg/day]
- titration: 50-100 mg increments q2-8 wks
- Usual maintenance: > 300mg/day [ok for renal impairment]
- max: 800-900 mg/day [normal renal fn]
Why is HLA-B *5801 testing not routinely done prior to allopurinol initiation?
- low PPV
- lack of cost-effective alternative ULT
Who would benefit from HLA-B *5801 testing more?
higher risk of allopurinol-induced SCAR e.g. renal impairment or older age.